tryptophan has been researched along with 3-(phenylamino)alanine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (91.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goda, Y; Maitani, T; Suzuki, J; Takeda, M; Uchiyama, M; Yoshihira, K | 1 |
| Belongia, EA; Gleich, GJ; Lin, F; Lundy, SK; Mayeno, AN | 1 |
| Adachi, J; Gomez, M; Smith, CC; Sternberg, EM | 1 |
| Adachi, J; Fujiwara, S; Mio, T; Naito, T; Nishimura, A; Sumino, K; Tatsuno, Y; Ueno, Y | 1 |
| Cosgrove, JW; Latham, PS; Sidransky, H; Verney, E | 1 |
| Hagiwara, Y; Kawase, Y; Sato, F | 1 |
| Brown, WR | 1 |
| Latham, P; Schwartz, A; Sidransky, H; Verney, E | 1 |
| Adachi, J; Gomez, M; Smith, CC; Sternberg, EM; Tatsuno, Y; Ueno, Y | 1 |
| Meyer, K; Simat, T; Steinhart, H; van Wickern, B | 1 |
| Sidransky, H; Verney, E | 1 |
| MartÃnez-Cabot, A; Messeguer, A | 1 |
1 review(s) available for tryptophan and 3-(phenylamino)alanine
| Article | Year |
|---|---|
Effects of tryptophan related compounds on nuclear regulatory control. Possible role in the eosinophilia-myalgia syndrome.
Topics: Alanine; Animals; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Liver; Nuclear Envelope; Proteins; Receptors, Cytoplasmic and Nuclear; RNA; Tryptophan | 1996 |
11 other study(ies) available for tryptophan and 3-(phenylamino)alanine
| Article | Year |
|---|---|
3-anilino-L-alanine, structural determination of UV-5, a contaminant in EMS-associated L-tryptophan samples.
Topics: Alanine; Chromatography, High Pressure Liquid; Eosinophilia-Myalgia Syndrome; Humans; Magnetic Resonance Spectroscopy; Tryptophan | 1992 |
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
Topics: Alanine; beta-Alanine; Brassica; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Plant Oils; Rapeseed Oil; Spain; Tryptophan; United States | 1992 |
Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in blood and organs of the Lewis rats.
Topics: Alanine; Animals; Chromatography, High Pressure Liquid; Drug Contamination; Drug Residues; Eosinophilia-Myalgia Syndrome; Female; Rats; Rats, Inbred Lew; Tissue Distribution; Tryptophan | 1995 |
Identification of four metabolites of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in rats.
Topics: Administration, Oral; Alanine; Animals; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Gas Chromatography-Mass Spectrometry; Kidney; Liver; Lung; Male; Phenylalanine; Rats; Rats, Wistar; Structure-Activity Relationship; Tissue Distribution; Tryptophan | 1994 |
Effect of 3-phenylamino-L-alanine on tryptophan binding to rat hepatic nuclear envelopes.
Topics: Alanine; Animals; Cell Nucleus; Drug Contamination; Female; Kinetics; Liver; Macrophages; Mice; Microsomes, Liver; Nuclear Envelope; Rats; Rats, Sprague-Dawley; Tritium; Tryptophan | 1994 |
Subchronic toxicity of 3-phenylamino alanine, an impurity in L-tryptophan reported to be associated with eosinophilia-myalgia syndrome.
Topics: Administration, Oral; Alanine; Animals; Blood Chemical Analysis; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Eosinophilia-Myalgia Syndrome; Female; Heart; Kidney; Liver; Macrophages, Alveolar; Male; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Testis; Tissue Distribution; Tryptophan | 1995 |
Comparative histopathologic evaluation of animal studies: murine studies with L-tryptophan and constitutents.
Topics: Alanine; Animals; Drug Combinations; Mice; Mice, Inbred Strains; Muscle, Skeletal; Muscular Diseases; Skin; Skin Diseases; Tryptophan | 1996 |
A comparative study of tissue distribution and excretion among three substances implicated in eosinophilia-myalgia syndrome.
Topics: Alanine; Animals; Biotransformation; Brain; Carbolines; Eosinophilia-Myalgia Syndrome; Humans; Kidney; Liver; Rats; Tissue Distribution; Tryptophan | 1996 |
Synthesis and analysis of contaminants in ems-related tryptophan.
Topics: Alanine; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan; Tryptophanase | 1996 |
Mouse strain and source of L-tryptophan affects hepatic nuclear tryptophan binding.
Topics: Alanine; Animals; Binding, Competitive; Cell Nucleus; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred NZB; Protein Biosynthesis; Selenic Acid; Selenium Compounds; Sodium Selenite; Tryptophan | 1997 |
Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome.
Topics: Alanine; Biotransformation; Chromatography, High Pressure Liquid; Disease Outbreaks; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Food Contamination; Foodborne Diseases; Humans; Microsomes, Liver; Plant Oils; Quinones; Rapeseed Oil; Spain; Spectrometry, Mass, Electrospray Ionization; Tryptophan | 2007 |